Back to Search
Start Over
Cipla gets Gujarat FDCA approval to manufacture generic remdesivir for COVID-19 under loan licensing pact with BDR Life
- Source :
- PharmaBiz. June 27, 2020
- Publication Year :
- 2020
-
Abstract
- Byline: Shardul Nautiyal In order to meet the demand for critically ill COVID-19 patients, Cipla Limited has received approval from Gujarat Food and Drug Control Administration (FDCA) to manufacture generic [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PharmaBiz
- Publication Type :
- Periodical
- Accession number :
- edsgcl.627799339